A multicenter phase II study of docetaxel (D) and carboplatin (CBDCA) combination in advanced non-small cell lung cancer (NSCLC). A preliminary analysis.

被引：0
|
作者：
Giannakakis, T [1 ]
Kakolyris, S [1 ]
Papadouris, S [1 ]
Mavroudis, D [1 ]
Kalbakis, K [1 ]
Souglakos, J [1 ]
Agelaki, S [1 ]
Passam, F [1 ]
Mixaki, J [1 ]
Georgoulias, V [1 ]
机构：
[1] Greek Cooperat Grp Lung Canc, Heraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
547P
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [31] Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer
    Lian Jiang
    Dao-yuan Wang
    Zhi-hua Zhu
    Liang-fa Tang
    Xin-heng Hou
    Hong-da Zhao
    Zheng Xie
    Dan-feng Wang
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 449 - 453
  • [32] Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer
    Jiang, Lian
    Wang, Dao-yuan
    Zhu, Zhi-hua
    Tang, Liang-fa
    Hou, Xin-heng
    Zhao, Hong-da
    Xie, Zheng
    Wang, Dan-feng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 449 - 453
  • [33] A phase I study of bortezomib, paclitaxel, carboplatin (CBDCA), and radiotherapy (RT) for locally advanced non-small cell lung cancer (NSCLC)
    Schild, S. E.
    Molina, J. R.
    Dy, G. K.
    Rowland, K. M.
    Sarkaria, J. N.
    Thomas, S. P.
    Northfelt, D. W.
    Kugler, J. W.
    Foster, N. R.
    Adjei, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Vinflunine (VFL) in combination with carboplatin (CBDCA) for treatment of advanced non-small cell lung cancer (NSCLC) in chemonaive patients (pts): Phase I and pharmacokinetic study
    Robinet, G
    Afenjar, K
    Gouva, S
    Planchard, D
    Zorza, G
    Tourani, J
    LUNG CANCER, 2005, 49 : S267 - S267
  • [35] A phase II retrospective trial of Carboplatin (CBDCA) and Alimta in refractory non-small cell lung cancer (NSCLC) with genetic polymorphisms analysis
    Ludovini, V.
    Pistola, L.
    Floriani, I.
    Meacci, M.
    Chiari, R.
    Stocchi, L.
    Tofanetti, F. R.
    Mare, M.
    Giuffrida, D.
    Crino, L.
    EJC SUPPLEMENTS, 2009, 7 (02): : 529 - 529
  • [36] A PHASE II RETROSPECTIVE TRIAL OF CARBOPLATIN (CBDCA) AND ALIMTA IN REFRACTORY NON-SMALL CELL LUNG CANCER (NSCLC) WITH GENETIC POLYMORPHISMS ANALYSIS
    Ludovini, Vienna
    Pistola, Lorenza
    Floriani, Irene
    Meacci, Marialuisa
    Chiari, Rita
    Stocchi, Lucia
    Tofanetti, Francesca Romana
    Mare, Marzia
    Giuffrida, Dario
    Crino, Lucio
    ANNALS OF ONCOLOGY, 2009, 20
  • [37] Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer (NSCLC).
    Miller, AA
    Case, D
    Atkins, J
    Giguere, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 649S - 649S
  • [38] Docetaxel (Taxotere®) and Carboplatin in the treatment of advanced non-small lung cancer (NSCLC)
    Schutte, W
    Bork, I
    Wollschlager, B
    Schadlich, S
    ANNALS OF ONCOLOGY, 1998, 9 : 90 - 90
  • [39] A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer
    Kosmas, C
    Tsavaris, N
    Koutras, A
    Makatsoris, T
    Mylonakis, N
    Tzelepis, G
    Dimitrakopoulos, A
    Spyropoulos, K
    Polyzos, A
    Karabelis, A
    Kalofonos, HP
    ONCOLOGY, 2005, 69 (04) : 333 - 341
  • [40] Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Karvounis, N
    Batzios, S
    Athanassiou, A
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3816 - 3821
12345